SIDEBAR
Xenograft Tumor Models
Model HT-29
Information on Cells and Models

Cell name:

HT-29


Other names for the model:

HT29、HT 29


Cell information:

HT-29 cells are derived from human colon cancer. The cells can synthesize IgA, CEA, TGFβ-binding protein and mucin. They express urokinase receptor, but no plasma zymogen activity is detected. They do not express CD4, but the cell surface Expresses galactosylceramide (a possible alternative receptor for HIV). This cell line is positive for oncogenes c-myc, K-ras, H-ras, N-ras, Myb, sis, and fos; the p53 gene is overexpressed, and a G→A mutation occurs at codon 273, resulting in Arg→His replace. Click to viewMore information.


Model information:

Subcutaneous inoculation, the mouse strain is BALB/c Nude. Approximately 9 days after vaccination can be grouped, and the administration time after grouping is approximately 25 days.

Quotation
******

* To view this data,Please Login Or Register access

Message
Talk to our experts?

Email: BD@truwaybio.com

Business: +86 185-0139-0702

Technology: +86 137-7300-5709

Website Usage Help: +86 188-6238-7270

Landline: +86 0512-80601059              

Design your Study now?
Frequently Asked Questions
Subscribe to newsletter
Get the latest news and exclusive offers from Truwaybio
Subscription